These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15035177)

  • 1. [Statins with hormone replacement therapy in postmenopausal women with low bone mineral density].
    Shintani M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():488-91. PubMed ID: 15035177
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.
    De Leo V; Morgante G; la Marca A; Lanzetta D; Cobellis L; Petraglia F
    Gynecol Endocrinol; 2003 Aug; 17(4):329-32. PubMed ID: 14503978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
    Tanriverdi HA; Barut A; Sarikaya S
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):63-8. PubMed ID: 15866088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on bone mineral density.
    Yilmaz A; Arikan O; Dokmetas S
    Saudi Med J; 2006 Sep; 27(9):1433-5. PubMed ID: 16951794
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
    Silvestri S; Thomsen AB; Gozzini A; Bagger Y; Christiansen C; Brandi ML
    Menopause; 2006; 13(3):451-61. PubMed ID: 16735942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.
    Boulos P; Sebaldt RJ; Goldsmith CH
    J Rheumatol; 2002 May; 29(5):1110-1. PubMed ID: 12022339
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women.
    Bakhireva LN; Shainline MR; Carter S; Robinson S; Beaton SJ; Nawarskas JJ; Gunter MJ
    Pharmacotherapy; 2010 Sep; 30(9):879-87. PubMed ID: 20795843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gerontologic aspects of postmenopausal measurement of bone density and prevention of osteoporosis].
    Wenderlein JM; Eissfeldt K; Heber F; Dannert E
    Geburtshilfe Frauenheilkd; 1995 Nov; 55(11):647-52. PubMed ID: 8707043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin D3 + estrogen/combination therapy].
    Mizunuma H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():475-9. PubMed ID: 15035174
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapies for osteoporosis.
    Jamal SA
    J Am Pharm Assoc (2003); 2004; 44(2):119; author reply 119. PubMed ID: 15098843
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial.
    Forsblad-d'Elia H; Carlsten H
    Ann Rheum Dis; 2011 Jun; 70(6):1167-8. PubMed ID: 21047910
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA; Going SB; Houtkooper LB; Flint-Wagner HG; Figueroa A; Metcalfe LL; Blew RM; Sharp SC; Lohman TG
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer RM; Arnaud CD; Zanchetta JR; Prince R; Gaich GA; Reginster JY; Hodsman AB; Eriksen EF; Ish-Shalom S; Genant HK; Wang O; Mitlak BH
    N Engl J Med; 2001 May; 344(19):1434-41. PubMed ID: 11346808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.